WallStSmart
DH

Definitive Healthcare Corp

NASDAQ: DH · HEALTHCARE · HEALTH INFORMATION SERVICES

$0.93
-1.14% today

Updated 2026-06-05

Market cap
$85.30M
P/E ratio
P/S ratio
0.36x
EPS (TTM)
$-1.67
Dividend yield
52W range
$1 – $5
Volume
0.3M

Definitive Healthcare Corp (DH) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2019202020212022202320242025
Total assets$1.72B$1.75B$2.12B$2.12B$1.83B$1.09B$735.49M
Cash & equivalents$8.62M$24.77M$387.50M$146.93M$130.98M$105.38M$163.63M
Current assets$36.11M$63.84M$444.23M$413.75M$380.44M$370.17M$257.61M
Total liabilities$504.91M$549.80M$617.78M$640.68M$626.73M$482.19M$356.50M
Current liabilities$69.92M$88.72M$123.12M$140.61M$170.68M$161.16M$156.79M
Long-term debt$434.85M$457.20M$263.81M$255.76M$242.57M$229.37M$156.09M
Shareholder equity$1.22B$1.20B$871.31M$948.92M$861.36M$444.38M$281.11M
Retained earnings$-55.76M$-109.86M$-17.84M$-25.06M$-227.45M$-640.57M$-779.51M
Accounts receivable$25.02M$33.11M$43.34M$58.80M$59.25M$53.23M$51.98M
Inventory$1.00$1.00$7.33M$10.39M$-3.43M
Goodwill$1.23B$1.26B$1.26B$1.32B$1.08B$393.28M$197.22M

Frequently asked questions

What is Definitive Healthcare Corp's revenue?

Definitive Healthcare Corp's trailing twelve-month revenue is $238.26M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is DH?

In its most recent fiscal year, DH ran a gross margin of 75.88%, an operating margin of -8.52%, and a net margin of -57.52%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does DH generate?

DH produced $37.06M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is DH's balance sheet healthy?

DH holds $163.63M in cash and equivalents against $156.09M in long-term debt, on $281.11M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.